Pathophysiology of Immune Checkpoint Inhibitor-Induced Myocarditis

SIMPLE SUMMARY: Myocarditis is an infrequent but highly hazardous complication of the cancer therapy of immune checkpoint inhibitors (ICIs). The study of the pathophysiology of this disease is an active field of research and a clearer comprehension of the mechanisms is crucial to provide an accurate...

Descripción completa

Detalles Bibliográficos
Autores principales: Jiménez-Alejandre, Rosa, Ruiz-Fernández, Ignacio, Martín, Pilar
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2022
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497311/
https://www.ncbi.nlm.nih.gov/pubmed/36139654
http://dx.doi.org/10.3390/cancers14184494

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9497311/
https://www.ncbi.nlm.nih.gov/pubmed/36139654
http://dx.doi.org/10.3390/cancers14184494

Ejemplares similares